ArticleBJS open2026
First series of da Vinci single-port robotic-assisted cervical oesophagectomy: single-centre IDEAL stage 2a/2b study.
Article in BJS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- One-Lung Ventilation Duration Is a Risk Factor for Pneumonia in Minimally Invasive and Robotic Esophagectomy.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent advances in robotic technology, particularly the da Vinci single-port (SP) system, have improved transcervical mediastinoscopic access by minimizing robotic arm collisions in confined spaces.
methodsThis study, based on IDEAL (Idea, Development, Exploration, Assessment, Long-term) framework, describes the first consecutive da Vinci SP robotic-assisted cervical oesophagectomy (RACE) procedures in patients with oesophageal carcinoma performed at the University Hospital Mainz. Patient demographics, neoadjuvant treatment, resection margins, lymph node yield, intraoperative parameters, postoperative recovery, complications, and mortality were assessed.
resultsThe study included 20 patients with primarily squamous cell carcinoma, with 70% of all patients having received neoadjuvant treatment. The surgical procedure demonstrated feasibility, evidenced by a 90% R0 resection rate and a mean(standard deviation) lymph node yield of 31(7). The mean(standard deviation) total operative time was 332(88) minutes, and the active console time was 91(48) minutes. Notably, there were no intraoperative complications or conversions. Patients experienced minimal postoperative pain, with no need for epidural or intercostal catheter analgesia; by postoperative day 5, all patients received analgesia on demand. Most patients began ambulating on the first postoperative day, and the median hospital length of stay was 8 (range 5-86) days. Postoperative complications included pneumonia in five patients and anastomotic leakage in four. Two patients died: one from fulminant pulmonary embolism and one from multiple organ failure secondary to sepsis following pneumonia and anastomotic insufficiency.
conclusionThe da Vinci SP system was successfully used for the first time in a clinical series of RACE procedures. SP RACE offers comparable operating times and lymph node retrieval to robotic transthoracic procedures, low postoperative pain and rapid recovery. However, the current scope of the SP RACE procedure is limited, and its outcomes warrant further prospective investigation to better define its role, refine patient selection, and evaluate long-term results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.